Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
MPT-0118 by Monopteros Therapeutics for Solid Tumor: Likelihood of Approval
MPT-0118 is under clinical development by Monopteros Therapeutics and currently in Phase II for Solid Tumor. According to GlobalData, Phase...
MPT-0118 by Monopteros Therapeutics for Breast Cancer: Likelihood of Approval
MPT-0118 is under clinical development by Monopteros Therapeutics and currently in Phase II for Breast Cancer. According to GlobalData, Phase...
MPT-0118 by Monopteros Therapeutics for Gastric Cancer: Likelihood of Approval
MPT-0118 is under clinical development by Monopteros Therapeutics and currently in Phase II for Gastric Cancer. According to GlobalData, Phase...
MPT-0118 by Monopteros Therapeutics for Chordoma: Likelihood of Approval
MPT-0118 is under clinical development by Monopteros Therapeutics and currently in Phase II for Chordoma. According to GlobalData, Phase II...